Ishita Drugs & Industries Ltd — Important, 08-10-2025: Company Update

Ishita Drugs and Industries has received confirmation from its Registrar and Share Transfer Agent regarding the efficient handling of dematerialization requests. The agent confirmed that all securities received from depository participants for dematerialization were processed, with confirmations sent to depositories. Additionally, physical share certificates were mutilated and cancelled after due verification, and the register of members was updated with the depositories' names within the required period. This confirms the company's continuous adherence to standards for electronic share management, ensuring smooth and compliant transactions for its shareholders.